Helius Medical Technologies Announces Authorization from Health Canada to Market Portable Neuromodulation Stimulator (PoNS®) Device for the Treatment of Gait Deficit Due to Mild and Moderate Symptoms from StrokeGlobeNewsWire • 03/09/23
Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023GlobeNewsWire • 03/06/23
Helius Medical Technologies to Showcase PoNS Therapy™ at American Physical Therapy Association's 2023 Combined Sections MeetingGlobeNewsWire • 02/15/23
Helius Medical Technologies, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022GlobeNewsWire • 01/23/23
Helius Medical Technologies to Present at the Virtual Q1 Investor Summit Microcap Event, January 26, 2023GlobeNewsWire • 01/19/23
Helius Medical Technologies, Inc. Announces Participation of Neurology Center of New England in its Therapeutic Experience ProgramGlobeNewsWire • 01/10/23
Helius Extends its Patient Therapy Access Program (PTAP), Bringing the Benefits of its PoNS® Device to More People with Multiple SclerosisGlobeNewsWire • 01/05/23
Helius Launches UpScript Telehealth e-Commerce Site, Making it Easier for Americans with Multiple Sclerosis to Access Neurotech that can Improve their Ability to WalkGlobeNewsWire • 01/03/23
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)GlobeNewsWire • 12/30/22
Helius Medical Technologies, Inc. (HSDT) Moves to Buy: Rationale Behind the UpgradeZacks Investment Research • 11/17/22
Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial ResultsGlobeNewsWire • 11/14/22
Helius Medical Technologies, Inc. Announces Participation of Dr. Prue Plummer and MGH Institute of Health Professions to its Therapeutic Experience ProgramGlobeNewsWire • 11/09/22
Helius Medical Technologies, Inc. Announces Participation of Oregon Health & Science University in its Therapeutic Experience ProgramGlobeNewsWire • 11/08/22
Helius to Showcase Innovative PoNS Device at ACRM's 2022 Conference – Demonstrating the Power of Neuromodulation to Help People with MS Improve their GaitGlobeNewsWire • 11/03/22
Helius Medical Technologies, Inc. to Release Third Quarter 2022 Financial Results on November 14, 2022GlobeNewsWire • 11/01/22
Helius Salutes Physical Therapists for Their Role in Helping People with MS Improve Their GaitGlobeNewsWire • 10/13/22
Helius Medical Technologies to Present at the ROTH Capital Partners Inaugural Healthcare Opportunities ConferenceGlobeNewsWire • 09/29/22
Helius Medical Technologies to Present at Upcoming Healthcare Investor Conferences in SeptemberGlobeNewsWire • 09/06/22